Mesoblast Limited
MESO
$16.11
$0.090.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.18% | 2.18% | -47.31% | -47.31% | -26.41% |
| Total Depreciation and Amortization | 94.29% | 94.29% | -14.82% | -14.82% | 19.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.69% | -20.69% | 213.73% | 213.73% | 209.80% |
| Change in Net Operating Assets | -232.53% | -232.53% | 91.58% | 91.58% | 6,353.13% |
| Cash from Operations | -33.87% | -33.87% | 22.27% | 22.27% | 32.77% |
| Capital Expenditure | -645.45% | -645.45% | 45.36% | 45.36% | -4.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.47% | -1.47% | 591.51% | 591.51% | -35.85% |
| Cash from Investing | -5,533.33% | -5,533.33% | 812.50% | 812.50% | -128.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 45.63% | 45.63% | -66.85% | -66.85% | -557.63% |
| Issuance of Common Stock | 542.23% | 542.23% | -96.62% | -96.62% | -70.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.98% | -27.98% | 66.02% | 66.02% | 28.20% |
| Cash from Financing | 1,652.20% | 1,652.20% | -113.49% | -113.49% | -88.84% |
| Foreign Exchange rate Adjustments | 227.91% | 227.91% | -149.31% | -149.31% | -2,914.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 946.39% | 946.39% | -499.79% | -499.79% | -132.40% |